Cargando…

Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women

BACKGROUND: Some studies suggest that hormonal contraception, pregnancy, and/or breastfeeding may influence rates of HIV disease progression. METHODS: From 1994 to 2012, HIV discordant couples recruited at couples' voluntary HIV counseling and testing centers in Lusaka were followed 3-monthly....

Descripción completa

Detalles Bibliográficos
Autores principales: Wall, Kristin M., Kilembe, William, Haddad, Lisa, Vwalika, Bellington, Lakhi, Shabir, Khu, Naw Htee, Brill, Ilene, Chomba, Elwyn, Mulenga, Joseph, Tichacek, Amanda, Allen, Susan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JAIDS Journal of Acquired Immune Deficiency Syndromes 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752415/
https://www.ncbi.nlm.nih.gov/pubmed/26379070
http://dx.doi.org/10.1097/QAI.0000000000000848
_version_ 1782415723526619136
author Wall, Kristin M.
Kilembe, William
Haddad, Lisa
Vwalika, Bellington
Lakhi, Shabir
Khu, Naw Htee
Brill, Ilene
Chomba, Elwyn
Mulenga, Joseph
Tichacek, Amanda
Allen, Susan
author_facet Wall, Kristin M.
Kilembe, William
Haddad, Lisa
Vwalika, Bellington
Lakhi, Shabir
Khu, Naw Htee
Brill, Ilene
Chomba, Elwyn
Mulenga, Joseph
Tichacek, Amanda
Allen, Susan
author_sort Wall, Kristin M.
collection PubMed
description BACKGROUND: Some studies suggest that hormonal contraception, pregnancy, and/or breastfeeding may influence rates of HIV disease progression. METHODS: From 1994 to 2012, HIV discordant couples recruited at couples' voluntary HIV counseling and testing centers in Lusaka were followed 3-monthly. Multivariate survival analyses explored associations between time-varying contraception, pregnancy, and breastfeeding and 2 outcomes among HIV-positive women: (1) time to death and (2) time to antiretroviral treatment (ART) initiation. RESULTS: Among 1656 female seropositive, male seronegative couples followed for 3359 person-years (PY), 224 women died [6.7/100 PY; 95% confidence interval (CI): 5.8 to 7.6]. After 2003, 290 women initiated ART (14.5/100 PY; 95% CI: 12.9 to 16.2). In a multivariate model of time to death, hormonal implant [adjusted hazard ratio (aHR) = 0.30; 95% CI: 0.10 to 0.98] and injectable (aHR = 0.59; 95% CI: 0.36 to 0.97) were significantly protective relative to nonhormonal method use, whereas oral contraceptive pill (OCP) use was not (aHR = 1.08; 95% CI: 0.74 to 1.57) controlling for baseline HIV disease stage, time-varying pregnancy, time-varying breastfeeding, and year of enrollment. In a multivariate model of time-to-ART initiation, implant was significantly protective (aHR = 0.54; 95% CI: 0.31 to 0.95), whereas OCP (aHR = 0.70; 95% CI: 0.44 to 1.10) and injectable (aHR = 0.85; 95% CI: 0.55 to 1.32) were not relative to nonhormonal method use controlling for variables above, woman's age, and literacy. Pregnancy was not significantly associated with death (aHR = 1.07; 95% CI: 0.68 to 1.66) or ART initiation (aHR = 1.24; 95% CI: 0.83 to 1.86), whereas breastfeeding was protective for death (aHR = 0.34; 95% CI: 0.19 to 0.62) and ART initiation (aHR = 0.49; 95% CI: 0.29 to 0.85). CONCLUSIONS: Hormonal implants and injectables significantly predicted lower mortality; implants were protective for ART initiation. OCPs and pregnancy were not associated with death or ART initiation, whereas breastfeeding was protective for both. Findings from this 18-year cohort study suggest that (1) HIV-positive women desiring pregnancy can be counseled to do so and breastfeed and (2) all effective contraceptive methods, including injectables and implants, should be promoted to prevent unintended pregnancy.
format Online
Article
Text
id pubmed-4752415
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher JAIDS Journal of Acquired Immune Deficiency Syndromes
record_format MEDLINE/PubMed
spelling pubmed-47524152016-03-19 Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women Wall, Kristin M. Kilembe, William Haddad, Lisa Vwalika, Bellington Lakhi, Shabir Khu, Naw Htee Brill, Ilene Chomba, Elwyn Mulenga, Joseph Tichacek, Amanda Allen, Susan J Acquir Immune Defic Syndr Epidemiology and Prevention BACKGROUND: Some studies suggest that hormonal contraception, pregnancy, and/or breastfeeding may influence rates of HIV disease progression. METHODS: From 1994 to 2012, HIV discordant couples recruited at couples' voluntary HIV counseling and testing centers in Lusaka were followed 3-monthly. Multivariate survival analyses explored associations between time-varying contraception, pregnancy, and breastfeeding and 2 outcomes among HIV-positive women: (1) time to death and (2) time to antiretroviral treatment (ART) initiation. RESULTS: Among 1656 female seropositive, male seronegative couples followed for 3359 person-years (PY), 224 women died [6.7/100 PY; 95% confidence interval (CI): 5.8 to 7.6]. After 2003, 290 women initiated ART (14.5/100 PY; 95% CI: 12.9 to 16.2). In a multivariate model of time to death, hormonal implant [adjusted hazard ratio (aHR) = 0.30; 95% CI: 0.10 to 0.98] and injectable (aHR = 0.59; 95% CI: 0.36 to 0.97) were significantly protective relative to nonhormonal method use, whereas oral contraceptive pill (OCP) use was not (aHR = 1.08; 95% CI: 0.74 to 1.57) controlling for baseline HIV disease stage, time-varying pregnancy, time-varying breastfeeding, and year of enrollment. In a multivariate model of time-to-ART initiation, implant was significantly protective (aHR = 0.54; 95% CI: 0.31 to 0.95), whereas OCP (aHR = 0.70; 95% CI: 0.44 to 1.10) and injectable (aHR = 0.85; 95% CI: 0.55 to 1.32) were not relative to nonhormonal method use controlling for variables above, woman's age, and literacy. Pregnancy was not significantly associated with death (aHR = 1.07; 95% CI: 0.68 to 1.66) or ART initiation (aHR = 1.24; 95% CI: 0.83 to 1.86), whereas breastfeeding was protective for death (aHR = 0.34; 95% CI: 0.19 to 0.62) and ART initiation (aHR = 0.49; 95% CI: 0.29 to 0.85). CONCLUSIONS: Hormonal implants and injectables significantly predicted lower mortality; implants were protective for ART initiation. OCPs and pregnancy were not associated with death or ART initiation, whereas breastfeeding was protective for both. Findings from this 18-year cohort study suggest that (1) HIV-positive women desiring pregnancy can be counseled to do so and breastfeed and (2) all effective contraceptive methods, including injectables and implants, should be promoted to prevent unintended pregnancy. JAIDS Journal of Acquired Immune Deficiency Syndromes 2016-03-01 2016-02-10 /pmc/articles/PMC4752415/ /pubmed/26379070 http://dx.doi.org/10.1097/QAI.0000000000000848 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.
spellingShingle Epidemiology and Prevention
Wall, Kristin M.
Kilembe, William
Haddad, Lisa
Vwalika, Bellington
Lakhi, Shabir
Khu, Naw Htee
Brill, Ilene
Chomba, Elwyn
Mulenga, Joseph
Tichacek, Amanda
Allen, Susan
Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
title Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
title_full Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
title_fullStr Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
title_full_unstemmed Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
title_short Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women
title_sort hormonal contraception, pregnancy, breastfeeding, and risk of hiv disease progression among zambian women
topic Epidemiology and Prevention
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4752415/
https://www.ncbi.nlm.nih.gov/pubmed/26379070
http://dx.doi.org/10.1097/QAI.0000000000000848
work_keys_str_mv AT wallkristinm hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT kilembewilliam hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT haddadlisa hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT vwalikabellington hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT lakhishabir hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT khunawhtee hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT brillilene hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT chombaelwyn hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT mulengajoseph hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT tichacekamanda hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen
AT allensusan hormonalcontraceptionpregnancybreastfeedingandriskofhivdiseaseprogressionamongzambianwomen